Mayne Pharma | MYX - Betriebsergebnis

Aktienkurs
2.51
Täglich Wechseln
0.09 3.72%
Monatlich
8.19%
Jährlich
-64.35%
Q2 Prognose
2.19




Betriebsergebnis Veränderung Datum
Ansell USD 146.5M 87.85M 2025-12
Avita Medical AUD -10.41M 742K 2025-12
Cochlear AUD 261.1M 135.55M 2025-12
CSL USD 2.64B 1.97B 2025-12
Healius AUD -22.6M 47.5M 2024-12
Integral Diagnostics AUD 19.28M 73.95M 2024-06
Medical Developments International AUD -36K 444K 2025-12
Nanosonics AUD 9.12M 3.82M 2025-12
Polynovo AUD 2.06M 1.18M 2025-12
Ramsay Health Care AUD 541.1M 3.9M 2025-12
ResMed USD 500.3M 37.95M 2025-12
Sigma Healthcare AUD 809K 13.76M 2024-12
Sonic Healthcare AUD 435.76M 193.66M 2024-12
Telix Pharmaceuticals AUD 8.04M 3.21M 2025-12